Eli Lilly and Company: UBS raises target price to $1,625 from $1,425
LLY•UBS raised its price target for Eli Lilly and Company to $1,625 from $1,425.
Related News
Nasdaq trade halt: volatility trading pause at 10:23 a.m.
ONEG•
AutoNation cuts 2026 capital spending forecast to $280 million-$290 million from $325 million
AN•
IBX partners with Sunlife, Symetra to expand employee benefits offerings
SLF•
Nasdaq pauses Purple trading for volatility at 9:47 a.m.
PRPL•
Hyatt Hotels Corp.: Macquarie raises target price to $210 from $200
H•